Madison H. Williams, M.D.
Department of General Oncology, Division of Cancer Medicine
Present Title & Affiliation
Primary Appointment
Assistant Professor, Department of General Oncology, Division of Cancer Medicine, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Assistant Professor, Department of Breast Medical Oncology, Division of Cancer Medicine, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Assistant Professor, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Assistant Professor, Department of General Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2015 | Texas A&M University College of Medicine, College Station, Texas, US, MD |
| 2010 | The University of Texas at Dallas (UTD), Richardson, Texas, US, Psychology, BA |
Postgraduate Training
| 2020-2021 | Clinical Fellowship, Hematology/Oncology, UT Health Science Center at San Antonio (UTHSCSA), San Antonio, Texas |
| 2015-2018 | Clinical Residency, Internal Medicine, University of Mississippi Medical Center (UMMC), Jackson, Mississippi |
Board Certifications
| 2021 | The American Board of Internal Medicine - Medical Oncology |
| 2018 | The American Board of Internal Medicine |
Experience & Service
Other Appointments/Responsibilities
Member, Program Evaluation Committee, UT Health Science Center at San Antonio (UTHSCSA) Hematology/Oncology Fellowship Program, San Antonio, TX, 2018 - Present
Member, Program Evaluation Committee, University of Mississippi Medical Center (UMMC) Internal Medicine Residency Program, Jackson, MS, 2017 - 2018
Member, Recruiting Committee, University of Mississippi Medical Center (UMMC) Internal Medicine Residency Program, Jackson, MS, 2015 - 2016
Honors & Awards
| 2021 | Chief Fellow, Hematology/Oncology Fellowship Program, UT Health Science Center at San Antonio (UTHSCSA) |
| 2020 | Chief Fellow, Hematology/Oncology Fellowship Program, UT Health Science Center at San Antonio (UTHSCSA) |
| 2020 | Department of Medicine 23rd Annual Medicine Research Day Junior Faculty or Clinical Fellow Poster Presentation Award, UT Health Science Center at San Antonio (UTHSCSA) |
| 2020 | Abstract Achievement Award, American Society of Hematology (ASH) |
| 2018 | Spirit of the Program Award, University of Mississippi Medical Center (UMMC) |
| 2018 | Robert S. Caldwell, MD, Memorial Award, University of Mississippi Medical Center (UMMC) |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Ta, A, Kaur, S, Mader, MJ, Franklin, K, Williams, MH, Williams, RA, Blaize, JP, Naqvi, A, Ananth, S, Song, M, Warnecke, BO, Pandya, AN, Djoumessi, LD, Nazarewicz, P, Espinoza-Gutarra, MR, Lucero, KT, Whitehead, JM, Al-Abayechi, A, Boyle, L, Lee, S, Roman Souza, G, Toro Velez, E, Mines, I, Nooruddin, ZI. The impact of race and ethnicity on diffuse large B-cell lymphoma outcomes within the veterans health administration (VHA). Leukemia and Lymphoma 65(8):1090-1099, 2024. PMID: 38619488.
- Moore AM, Nooruddin Z, Reveles KR, Datta P, Whitehead JM, Franklin K, Alkadimi M, Williams MH, Williams RA, Smith S, Reichelderfer R, Cotarla I, Brannman L, Frankart A, Mulrooney T, Hsieh K, Simmons DJ, Jones X, Frei CR. Durvalumab Treatment Patterns for Patients with Unresectable Stage III Non-Small Cell Lung Cancer in the Veterans Health Administration (VHA): A Nationwide, Real-World Study. Curr. Oncol 30(9):8411-8423, 2023. PMID: 37754526.
- Williams, MH, Williams, RA, Hernandez, B, Michalek, J, Parma, DL, Arora, SP. Clinicopathologic differences and mortality among Latinos and non-Latino whites with gastric cancer at a majority-minority cancer center in South Texas. Journal of Gastrointestinal Oncology 12(4):1301-1307, 2021. PMID: 34532089.
- Williams MH, Williams RA, Hernandez B, Michalek J, Parma DL, Arora SP. Clinicopathologic Differences and Mortality among Latinos and non-Latino Whites with Gastric Cancer at a Majority-minority Cancer Center in South Texas. J Gastrointest Oncol 12(4):1301-1307, 2021. PMID: None.
- Williams MH, Williams RA, Mahadevan D, Ramamurthy C. Evolving Therapies for Urothelial Carcinoma: Novel paradigms and future directions. Oncology & Hematology Review 16(2):82-89, 2020. e-Pub 2020. PMID: None.
- Ananth S, Williams MH, Williams RA, Blaize JP, Gregorio D, Song MM, Rosas GM, Djoufack Djoumessi LR, Warnecke B, Pandya A, Dee V, Mader M, Toro JJ, Franklin K, Nazarewicz P, Nooruddin Z. Impact of age on treatment and outcome in newly diagnosed DLBCL (Diffuse large B-cell Lymphoma) patients in the United States veteran population (2011-2017). Blood 136(S1):1, 2020. PMID: None.
- Williams RA, Williams MH, Blaize JP, Ananth S, Gregorio D, Rosas GM, Song MM, Warnecke B, Pandya A, Djoufack Djoumessi LR, Dee V, Nazarewicz P, Toro JJ, Franklin K, Mader M, Nooruddin Z. Impact of differences in time from diagnosis to treatment on DLBCL response and survival outcomes: a VA study. Blood 136(S1):1-2, 2020. PMID: None.
- Williams, MH, Mahadevan D. In Silico analyses of host immunity and stroma provide prognostic factors in early stage pancreatic ductal adenocarcinoma (PDAC). Ann Transl Med 8(6):259, 2020. PMID: 32355703.
- Williams MH, Hansen D, Sheehan N. A case of metastatic melanoma of the heart diagnosed ante-mortem. J Miss State Med Assoc 59(9):396-398, 2018. PMID: None.
- Selvamani A, Williams MH, Miranda RC, Sohrabij F. Circulating miRNA profiles provide a biomarker for severity of stroke outcomes associated with age and sex in a rat model. Clin Sci (Lond) 127(2):77-89, 2014. PMID: 24428837.
- Sohrabji F, Williams MH. Stroke neuroprotection: Oestrogen and insulin-like growth factor-1 interactions and the role of microglia. J Neuroendocrinology 25(11):1173-1181, 2013. PMID: None.
Other Articles
- Taverna, J, Hung, CN, Williams, MH, Williams, R, Chen, M, Kamali, S, Sambandam, V, Hsiang-Ling Chiu, C, Osmulski, PA, Gaczynska, ME, Dearmond, DT, Gaspard, C, Mancini, M, Kusi, M, Pandya, AN, Song, L, Jin, L, Schiavini, P, Chen, CL Ex vivo drug testing of patient-derived lung organoids to predict treatment responses for personalized medicine. Lung Cancer 190, 2024. PMID: 38520909.
Abstracts
- Williams MH, Williams RA, Hansen D, Puneky L, Wilkinson K. Recurrent Cervical Cancer: A Unique Path to Diagnosis. J Investig Med 66(2):351-640, 2018. PMID: None.
- Williams MH, Capra C, Milner C. A Rare Case of Epidural Follicular Lymphoma. J Investig Med 66(2):351-640, 2018. PMID: None.
- Williams MH, Williams RA, Salim S, Sheehan N. Denosumab Associated Severe Hypocalcemia in a Patient with Chronic Kidney Disease. J Investig Med 65(2):396-568, 2017. PMID: None.
- Williams RA, Williams MH, Wright N, Hansen D, Sheppard J. Don't Always Take Cancer at Face Value: Multiple Primaries in an AIDS Patient. J Investig Med 65(2):396-568, 2017. PMID: None.
- Williams MH, Capra C, Abdo A, Montgomery GV. Atypical Presentation of Advanced Pancreatic Cancer. J Investig Med 64(2):488-726, 2016. PMID: None.
Patient Reviews
CV information above last modified October 23, 2024